Synexa Life Sciences
Ayesha Khan is a Senior Scientist at Synexa Life Sciences since August 2022, specializing in fee-for-service analyses of biological samples and bioanalytical assay development for human clinical trials. Previous experience includes a postdoctoral fellowship at UCL, managing the LAG3 project focused on T cell studies in SLE patients, and a supervisory role at Richer Education, overseeing logistics for educational sessions. Ayesha has also tutored students in various subjects, served as a PhD candidate at UCL, and completed a Master's in Infection & Immunity. Educational qualifications include a BSc in Biomedical Sciences and a PhD in Infection & Immunity from UCL, complemented by early work experience in research and data entry.
This person is not in any offices
Synexa Life Sciences
Synexa Life Sciences is a global provider of biomarker and bioanalytical services, specialising in the development, validation, and delivery of a wide range of complex and custom-designed assays. With a team of 150 across five global laboratory locations; Cape Town, London, Berlin, Turku (Finland) and Rockville (Maryland USA), we provide innovative solutions to support our customers to achieve their clinical milestones. Our main areas of expertise include biomarker identification and development, clinical bioanalysis, soluble biomarker analysis (utilising MSD, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry and ELISpot) and genomic services to support clinical trials and translational studies. We pride ourselves on our deep scientific expertise and our ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis. We partner with our customers to contribute to the furtherment of scientific development and ultimately better management and treatment of human health. Synexa, improving the quality of human health through innovative biomarker and bioanalytical solutions.